ArticleACS omega2026
Green Synthesis, Characterization, and the Prediction of Its Thermochemical Properties of the Isomers 3,4- and 3,5-Bis(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)benzoic Acid.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The solid-state synthesis of the 3,4- and 3,5-bis-(1,3-dihydro-1,3-dioxo-2H-isoindole-2-yl) benzoic acid isomers (hereafter referred to as DIAs) is reported using a solvent-free strategy aligned with the principles of green chemistry. A previously reported methodology was employed, and the relationship between molecular structure and thermal behavior was evaluated. Structural characterization was performed by infrared spectroscopy (FTIR), proton nuclear magnetic resonance (
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.